Upadacitinib dose increase to 45 mg daily for refractory atopic dermatitis
Fields of Study & Subjects
Dermatology and Skin Diseases
Asthma and respiratory diseases
Psoriasis: Treatment and Pathogenesis
Publication details
- Journal / source
- Journal of the American Academy of Dermatology
- Volume
- 94
- Issue
- 6
- Pages
- 1816–1819
- Publication date
- 14 February 2026
- Language
- EN